Intramuscular hydroxocobalamin is first-line treatment in the UK for B12 deficiency with neurological symptoms
180Mguez-BurbanoMJWyattCLewisJERodrguezADuncanR
Additionally, the invention relates to a pharmaceutical or diagnostic composition comprising the BPC peptide salts of the present invention, optionally in conjunction with one or more pharmaceutically acceptable carriers, as well as processes for preparing these compositions
The current mechanistic picture, assembled from Sikiric-group reviews and independent confirmatory work (Chang 2011, 2014
Frias JP, Hsia S, Eyde S, Liu R, Ma X, Konig M, et al
Ongoing research aims to investigate the specific pathways and targets through which BV and its constituents exert their pharmacological effects, both beneficial and detrimental, to optimize its therapeutic potential while minimizing adverse reactions (Pandey et al., 2023a)